In this paper we considered a missing binary outcome problem in causal inferences for a randomized encouragement design study. We proposed both moment and maximum likelihood estimators for the marginal distributions of potential outcomes and the local complier average causal effect (CACE) parameter. We illustrated our methods in a randomized encouragement design study on the effectiveness of flu shots.
Introduction
A traditional randomized clinical trial is the established gold standard for estimating the causal effects of treatments. However, for some treatments, it is impossible to perform such a randomized trial due to ethical and other reasons. For example, in our flu shot reminder study, it would be unethical to randomize high-risk adult patients to receive or not to receive flu shots in order to evaluate causal effects of having flu on patient outcomes. A better way to learn about treatment causal effects is to perform a randomized encouragement design study (EDS). A randomized EDS randomly assigns subjects to receive or not to receive an encouragement for the use of a treatment.
In recent years, there has been a rapid growth in utilizing encouragement designs to study causal treatment effects. Since the randomization to encouragement leads to a natural instrumental variable under some plausible assumptions, the randomized EDS provides a tool for estimating causal effects of the treatment on patient outcomes.
There are three basic elements in a randomized controlled EDS that make statistical analysis more difficult than in standard drug studies. The first is an encouragement to perform suggested clinical actions is randomly given to clinicians; the second is subsequent clinical actions are recorded; and the third element is that final patient outcomes are recorded. The focus of the analysis is the causal effects of the encouraged clinical actions on subsequent patient outcomes. One major analytic issue in the EDS is non-compliance of subjects with suggested treatments, and there could be a large number of subjects with non-compliance. For example, in the randomized EDS of flu shots, patients' physicians were randomly assigned to whether to receive reminders about giving flu shots to their patients. A physician could decide to give flu shots to his/her patients, regardless of whether he/she received a reminder.
Rubin [12, 13, 14] developed a framework for the causal analysis in randomized trials with noncompliance using potential outcomes. This approach allows one to estimate the causal effect of the treatment actually received on patient outcomes. Neyman [9] first formalized the ideas of using potential outcomes in randomized trials to define the effect of the treatment actually received on outcomes [14] . Rubin's causal model [6] extended Neyman's formulation to observational studies and formulated an explicit model for the assignment mechanism exhibiting possible dependence on all potential outcomes. The resulting model allows one to use frequentist and Bayesian methods for inferring causal effects in both randomized and observational studies. For all-or-none compliance studies without any missing outcome values, both the likelihood approach and Bayesian approach have been proposed. For example, Cuzick et al [2] developed likelihood methods for causal analysis of studies. Imbens and Rubin [7] , and Hirano et al. [5] developed likelihood and Bayesian methods for causal analysis of randomized studies. Frangakis et al. [4] extended the Bayesian causal analysis proposed by Hirano et al. (2000) to clustered data.
When some patients were missing their outcomes, Frangakis and Rubin [3] developed a moment estimator for the intention-to-treat (ITT) effect and the local complier average causal effect (CACE) of the treatment on the binary outcome in a simple two-treatment randomized trial in which only intervention patients could receive the new treatment (e.g. only control subjects could be noncompliers). When outcomes were continuous, Yau and Little [15] extended Frangakis and Rubin's method to a longitudinal study which had only compliers and never-takers, and Peng et al. [11] further extended Yau and Little's results to the case when the missing value could occur in both the outcomes and baseline covariates.
Barnard et al. [1] extended Frangakis and Rubin's method to a longitudinal study with crossover non-compliance (e.g. both intervention and control subjects could be non-compliers) when outcomes were continuous. Their method focused on parametric models (e.g. a censored normal model for their outcomes).
In this paper, we focus our attention on binary outcomes and generalize the moment method proposed in Frangakis and Rubin [3] to a randomized clinical trial with crossover non-compliance and missing data, as in our flu shot reminder study. We also develop a maximum likelihood (ML) approach for this type of non-compliance problem with missing data. As in the previous papers, we focus our attention on the local complier average causal effect (CACE). This paper is organized as follows. In Section 2, we describe a randomized encouragement design study on flu shot, which has motivated this research. In Sections 3, we provide some basic notation needed for defining the Rubin's causal model, and in Section 4, we define complier types based on potential outcomes on the treatments actually received. In Section 5, we define causal effect parameters. In Section 6, we give necessary assumptions for making causal inferences when both the problems of non-compliance and missing data exist. In Sections 7, 8, and 9, we derive both the moment and maximum likelihood (ML) estimators for marginal distributions of potential outcomes as well as causal effect parameters.
In Section 10 we present the results from applying the proposed method to our flu shot data set.
All technical details are presented in Appendix A.
A Real Study
From observational studies, it has been shown that vaccination has improved outcomes in vaccinated patients. Hence, health officials in most countries recommend annual influenza vaccination for elderly persons and other people at high risk of influenza. However, no controlled randomized trials of the effects of influenza vaccination on pulmonary morbidity in high-risk adults have been published (McDonald et al, 1992) . One possible reason for the lack of randomized trials is that widely accepted recommendations for vaccination raise ethical barriers against performing randomized controlled trials because it would require withholding vaccination from some subjects.
One way around this impasse would be to perform a randomized trial of an intervention that increases the use of influenza vaccine in one group of patients without changing the use of influenza vaccine in another group. McDonald and his colleagues [8] used this idea to study influenza vaccine efficacy in reducing morbidity in high-risk adults, using a computer-generated reminder for flu shots (McDonald et al, 1992) . The study was conducted over a three-year period (1978) (1979) (1980) in an academic primary care practice affiliated with a large urban public teaching hospital. Physicians in the practice were randomly assigned to either an intervention or a control group at the beginning of the study. Since physicians at the clinic each care for a fixed group of patients, their patients were similarly classified. During the study period, physicians in the intervention group received a computer generated reminder when a patient with a scheduled appointment was eligible for a flu shot. Our data set involved randomization of an encouragement by doctor, and doctors had multiple patients. However, the study did not keep information on the clustering of patients by doctor. Hence, for the purpose of illustrating the proposed method and avoiding an overly cumbersome analysis involving unknown cluster indicators, we assume exchangeability of patients. Each subject's randomized intervention, actual treatment receipt, and outcome of interest constitute the minimal data necessary to analyze this type of study. The example data are shown in Table 1 below. Note that when Y i is observed, R i = 1 by definition, so the first two lines include those subjects with full data (R = 1, Y, Z, D) and the last line includes those subjects with incomplete data (R = 0, Z, D). Table 1: Example Data   R=1  Z=0,D=0  Z=0,D=1  Z=1,D=0  Z=1,D=1   Y=0  573  143  499  256   Y=1  49  16  47  20   R=0, Y=·  492  17  497  9 The main research question in the study is to estimate the causal effect of having a flu shot on flu-related patient outcomes, such as flu-related hospitalization. Our hypothesis is that having flu shots will significantly decrease flu-related hospitalization. To assess the causal effect of flu shot on the outcome, we have to deal with the both problems of non-compliance and missing outcomes.
Basic Notation
Additional notation is needed to clearly state our models. In our flu shot reminder study, we are 
) is a vector of potential outcomes for subject i. Note that although we use a double-argument notation for
, it is actually a function z only. Our observed data would consist of Z i , To ease the notation burden, we define some statistics of the observed data Z i , D i , Y i , and
, which represents the total number of subjects in the sample who have observed outcomes and are assigned to the treatment z and actually receive the
, which is the total number of hospitalized subjects who have observed outcomes and are assigned to treatment z and receive treatment d. Let
, which is the total number of subjects in the sample who are missing their outcomes and are assigned to the treatment z and receive the treatment d.
Complier types
One key idea in Rubin's causal model is to define the complier type, C i , of subject i based on potential outcomes D i (1) and D i (0). Because D i (1) and D i (0) each can take two values, the complier type C i has four different values, n for never-takers, a for always-takers, c for compliers, and d for defiers: Subjects whose treatment status is always the opposite of their treatment assignment are referred to as defiers. Also, we assume all-or-none compliance: subjects are assumed to have a fixed, though possibly unknown, complier type which does not change. If we further assume the monotonicity assumption that D i (1) ≥ D i (0) for all subjects i (i.e. no defiers), the complier status is 0) , we know the subject is a never-taker; similarly, when (Z i , D i ) = (0, 1), we know the subject is an always-taker. For subjects with (Z i , D i ) = (0, 0), we cannot tell whether the subject is a never-taker or a complier; similarly, for subjects with 1) we cannot tell whether the subject is an always-taker or a complier. Here arises the principal difficulty with using only marginal quantities to estimate causal parameters: some observed data arise from a mixture of the outcome distributions of different complier types. Let us define the probability of complier type given the observed treatment assignment and receipt as:
. We denote the probability of assigning a subject to the treatment group and the probability of being in a particular complier type as:
respectively.
Causal Parameters of Interest
In order to define our causal parameters, we need to make some further assumptions. The first basic assumption is the Stable Unit Treatment Value Assumption (SUTVA), which assumes no interference between study patients. Under the SUTVA, we can define intention-to-treat (ITT) 
In this article, we concentrate on estimation of the CACE.
Further Assumptions and their Implications in Missing Outcomes
With additional missing values in the outcome, to estimate causal parameters we need to make the following additional assumptions.
1. Latent ignorability: potential outcomes and associated potential non-response indicators are independent within each latent complier type. 
as the conditional probability of outcome given the complier type and treatment assignment,
as the probability of observing outcome Y for subjects with Z i = z and C i = t. Then we can express the compound exclusion assumption as
Estimation
In this section, we discuss methods for estimating the parameters ψ zdt , γ zt , and ω t . Under our assumptions, the complier status, C i , is known when
The observations for which Z i = D i , on the other hand, are mixtures of different compliance strata, and the proportion of each compliance stratum within the observed cell is unobservable. When (Z i , D i ) = (0, 0), the subject can be either a complier or a never-taker; when (Z i , D i ) = (1, 1) the subject can be either a complier or an always-taker. Hence, many of the conditional probabilities of complier types given the observed data are known. In fact, among ψ zdt 's, only ψ n00 and ψ a11 are unknown parameters. To simplify notation we denote the two unknown parameters as ψ n = ψ n00 and ψ a = ψ a11 . If the unconditional probabilities of complier types are of interest, we can compute them from the parameters ψ tzd and the observed data. Therefore, the marginal distributions of potential outcomes and the missing data mechanism are defined by the eleven parameters, ξ, ψ n , ψ a , η n , η a , η 0c , η 1c , γ n , γ a , γ 0c , and
Next, we propose two methods for estimating the vector of parameters θ.
Moment Estimators
We apply the method of moments to obtain estimators of the causal parameters of interest, using a principal stratification with the binary outcome. The method of moments equates sample moments to population moments and solves the resulting equations for the parameters of interest.
In Appendix A, we show the following proposition regarding the moment estimator for θ. 
For parameters in complier subpopulations, the moment estimators are
Using the results in Proposition 1, we can also estimate the proportions of the three complier types,
Hence,
Similarly, we can show that
where N = total number of subjects = N 00 + M 00
Under the assumption of monotonicity, ω c = 1 − ω n − ω a and the estimator of ω c is
Since we can write CACE = η 1c − η 0c , we obtain the estimator for the local complier average causal effect CACE as follows:
We apply the bootstrap method to compute the standard errors for the moment estimators.
Maximum Likelihood Estimation
One potential problem with the moment estimators in Section 8 is that they are not constrained to the range of the parameters they estimate. In this section, we also develop maximum-likelihood estimators of causal parameters.
We first derive the observed-data likelihood function for the subjects with observed outcomes
, and denote it L o (θ). We then derive the observed-data likelihood function for the subjects with missing outcomes (
Next we give the expressions for L o (θ) and L m (θ). For subjects with observed outcomes R i = 1, we have
Since P (Z i = 1) = ξ and P (Z i = 0) = 1 − ξ and
we obtain that
For subjects with missing outcomes R i = 0, we have
Hence we obtain that
Therefore, the observed-data log-likelihood l(θ) is
It is also easy to show that
we obtain
To obtain the maximum likelihood estimatorθ for θ, we can directly solve the score function of θ, which is the partial derivative of the log likelihood with respect to θ, S(θ) = ∂l(θ)/∂θ. Using the Fisher information matrix, we obtain standard error estimates for those parameters.
Since the observed-data likelihood given in Equation 2 has a complicated form involving a mixture structure over a large amount of missing-data, directly maximizing the observed-data likelihood may present a computational challenge. To avoid directly maximizing the observed-data likelihood, we propose an EM algorithm to find the ML estimatorθ of θ by treating C i as missingdata because the complete-data likelihood has a simple form if C i were known for all patients.
In the E-step of the EM algorithm, we compute the conditional expectation of the completedata likelihood function given the previous parameter estimate, denoted by θ (k) , and the observed data. In the M-step, we maximize this expectation with respect to θ, typically by differentiation, to obtain the new parameter estimate θ (k+1) . We repeat the E-and M-steps until the process converges at step K, where
Here is a very small constant. The one major advantage of using the EM algorithm here is that the EM algorithm yields an explicit solution for θ (k+1) in terms of θ (k) and the observed data, which simplifies computation.
The complete-data likelihood function is given by
.
Using this expression, in Appendix B we derive the E-and M-steps in the EM algorithm. Before we state our EM algorithm results, we need additional notation. Let us define
x yrzt = number of subjects with Y = y, R = r, Z = t and C = t where y, r and z take values of 0 or 1 and t = a, n or c. 
M-step: we find the next iteration estimate θ
, and θ (k+1) has the following explicit expressions.
, where
For a proof, see Appendix B.
Simulations
We conduct simulation studies to assess the finite sample performance of proposed moment and and the mean. We report bias and mean squared error of the parameter estimates in Table 2 below.
Our simulation results show that both the moment and ML estimators are almost unbiased and have small mean squared errors. The ML estimators have slightly smaller MSE than the Moment estimators.
We conduct further simulations to assess the performance of the moment and ML estimators when latent ignorability or compound exclusion criteria is violated. In the simulation study without latent ignorability, we let the probability of having missing outcomes depend on the value of Y but still hold γ n = 0.5, γ a = 0.6, γ 0c = 0.7 and γ 1c = 0.8, marginally. The results are shown in Table 3 .
In the simulation without compound exclusion criteria, we let P (Y = 1) and P (R = 1) depend on the Z but still satisfy η n = 0.2, η a = 0.3, γ n = 0.5 and γ a = 0.6, marginally. The simulation results are shown in Table 4 .
Results
In this section, we illustrate the application of the proposed methods in the flu shot data set discussed in Section 2.
We summarize both the moment and ML estimates in Table 5 along with their associated standard errors. Convergence is rapid and stable with respect to various different starting points, indicating that this solution is a global maximum; the log-likelihood has no local maxima. These maximumlikelihood estimates also solve the score equations, as required. Unfortunately, there is a boundary value problem with respect to γ 1c . The likelihood method yielded an estimate of 1.0 ( γ 1c = 1.000).
Since the moment method can yield probability estimates of greater than 1.0, we constrict them to be tween 0 and 1.
The moment and ML methods yielded identical estimates for η n , η a , and γ n . The agreement is very close for complier distributions ω n , ω a , and ω c . The conditional complier distributions, ψ n There are several limitations to the results of this application; some of which are due to a limitation in the data collection. First, our data set involved randomization of an encouragement to physicians, and physicians had multiple patients. Due to lacking of information on the clustering of patients by physicians, for the purpose of illustrating the proposed method, we ignored a possible clustering effect.
Second, although the exclusion restriction for never-takers is reasonable, the exclusion restriction for always-takers may be questionable. Never-takers are these patients who would not receive the flu shot in any case. If those patients and their physicians did not regard the risk of flu as high enough to warrant a flu shot, it might be reasonable to assume that these patients were completely unaffected by their physicians' receipt of the letter, implying that the exclusion restriction would be satisfied for the never-takers. However, for the always-takers, the situation may be quite different.
The always-takers are patients who would receive the flu shot irrespective of the receipt of the encouragement letter by their physician. Such patients are most likely at higher risk for getting the flu. If these patients and their physicians regard the risk of getting flu as high enough to warrant flu shot, they might be also subject to other medical actions. Therefore, it is possible that the flu reminder may prompt the physician to take other measures beyond giving the flu shot. If these other measures affect health outcomes, the exclusion restriction would be violated. Given these limitations we advise caution with the clinical interpretation of the results.
Conclusion
In this paper we have proposed both the moment and ML methods for estimating the causal marginal outcome distributions, as well as the local complier average causal treatment effects when both the problems of missing-data and noncompliance exist. Our methods are extensions of the method proposed by Frangakis and Rubin [3] . The four crucial assumptions in our methods are SUTVA, monotonicity assumption, compound exclusion assumption and, latent ignorability.
We have investigated the sensitivity of both the proposed moment and ML estimators to the departure from these assumptions and reached a similar conclusion as the one in O'Malley and
Normand [10] . We illustrated the proposed methods in the randomized encouragement design flu shot study. It is worthwhile to point out that we have investigated the alternative parametrization as suggested by a reviewer by using factorization,
this parametrization leads to some unidentifiable parameters.
One future research topic would be to extend the proposed moment method to a longitudinal setting considered by both Yau and Little [15] and Barnard et al. [1] . Using the moment method, we can then perform a goodness-of-fit test for the parametric models used in these papers.
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[ For notational convenience, we define the following three parameters that are directly estimable from the observed data: . Therefore, we obtain that
,
Therefore we obtain the moment estimators of ψ n and ψ a as follows:
We next derive the moment estimators for η n , η a , γ n , and γ a . By the latent ignorability, we
. Hence, we have
Therefore, the moment estimators for η n and η a are
Using the compound excludsion asumption, we have as follows:
and
Hence the moment estimators for γ n and γ a are
Next we derive moment estimators for complier-type parameters, γ zc and η zc . Similar to the estimators for the ψ n and ψ a parameters, these estimators are not true moment estimators, but functions of other estimators and the observed data. Unlike the ψ t 'moment' estimators, which are functions of a single estimator and the observed data, these estimators are functions of two other estimators and the observed data. They each contain a 1 1−ψ t factor and also a product term, both of which contribute to the variability of the estimator. We first observe that we can express the directly estimable quantity P (R = 1 | Z = z, D = d) as mixtures of the unobserved γ zt and ψ zdt , as well as the ratio of
By taking z = 0 and 1 in the above expression, we obtain that
Solving γ 0c and γ 1c in (3), we obtain that
are unbiased estimators of π zd and ξ zd , we obtain the moment estimators of γ 0c and γ 1c as follows:
We can show that
We can also show that
Similar to the expression for
ν 00 π 00
, we obtain
By solving for η 0c and η 1c in the above equations, we obtain that
is an unbiased estimator of ν zd , we obtain the moment estimators of η 0c and η 1c as
Appendix B. A Proof for Proposition 2
where P (Z) = ξ can be dropped during the EM steps.
Hence, by defining
x yrzt = number of subjects withY = y, R = r, Z = t and C = t,
we obtain the complete-data log-likelihood as
In the E step, we take the expectation of the complete-data log-likelihood, given the observed data and the previous parameter estimate θ = θ (k) and obtain the following result:
· r 00 x (k+1) 010n
· (N 00 − r 00 ) 
In the M step, we find the next iteration estimate θ (k+1) by finding the roots of the partial 
